Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
Disease Risk Management A hot application scenario of medical artificial intelligence is disease risk management. When applies to a specific disease treatment area, AI can
At present, artificial intelligence technology is increasingly mature and permeates all walks of life, among which the deep collection of artificial intelligence and medical treatment
We are pleased to announce Grace Fu Palma, CEO of China Med Device, LLC, was selected to chair the opening panel of China Regulatory and
In 2017, NMPA (CFDA) announced the first batch of approved combination products in China In 2017, NMPA (CFDA) announced the first batch of approved combination
In 2017, CFDA announced the first batch of approved combination products in China In 2017, CFDA announced the first batch of approved combination products since
The China State Council issued tariff plan worth $60 billion on the 2nd batch of goods imported from U.S. on August 3. It will impose
China State Council published an article on AI medical device on July 9th, aiming to propel China to the leadership of AI devices, especially AI-infused
Two Invoice Policy in China Brings Great Opportunities for The Integration of Medical Device Industry At the end of January 2018, the “Two Invoice Policy”
“Two Invoice Policy” means that the pharmaceutical production enterprise issues one invoice to the circulation enterprise, and the circulation enterprise issues one invoice to the
Medical implants The 3D printed titanium mesh implant promotes bone regeneration In the medical field, the treatment of large bone defects or injuries remains a
Thanks to advantages such as high precision, solidity of finished products, and the ability to copy complex geometric models, 3D printing technology is increasingly used
Abbott is a globally diversified healthcare company with over $21 billions in sales and 94,000 employees in 150 countries. Its revenues are splits 58% in